Paris-based Primaa, an AI software developer for cancer diagnostics, has raised €7 million. The funding will support European deployment, feature development, and international expansion, particularly in the United States with planned FDA certification activities.
Primaa raises €7M to accelerate product growth and international expansion
October 29, 2025